Poor understanding about vaccine capacity was one of the reasons why the world did not have the infrastructure needed to manufacture sufficient doses. This blogs proposes three actions to start tracking manufacturing capacity better and create robust estimates for the world’s vaccine manufacturing capacity.
CGD Policy Blogs
This first episode of the new Africa-centered podcast series Lagos to Mombasa examines how African governments can shape their responses to the pandemic and prepare for the future. Patrick Tippoo of Biovac and the African Vaccine Manufacturing Initiative and Prashant Yadav from CGD join Gyude Moore to discuss options and opportunities.
It was the best of times, it was the worst of times, it was the age of vaccines and reopening, it was the age of the Delta variant and closing down again. For many of us, the past year and a half has been stranger than fiction, a whirlwind of emotions and uncertainties. We hope this year's summer reading list provides you with new stories, strategies, and distractions to get you through the next few socially-distanced, masked-up months.
Most oxygen disasters across India could have been avoided. This blog describes the current model of medical oxygen supply in India, outlines the response to the oxygen crises, including the problem of severe oxygen shortages in some Indian states, and provides recommendations on how India could prevent the next crisis stemming from shortages in oxygen.
Shock to the System: Understanding Global Medical Supply, Shortages in COVID-19 Crisis, and How to Prepare for Future Disruptions
Since March of 2020, COVID-19 changed most aspects of life as we knew it, from our personal day-to-day activities to the systems, processes, and structures that keep the global economy interconnected and moving. This included pharmaceutical production and distribution, where anecdotal evidence suggested production problems, export bans, and trade disruption could significantly impact vital medicines access in low- and middle-income countries.
A lot of recent discussions focus on how to expand COVID-19 vaccine manufacturing capacity in low- and middle-income countries (LMICs). The conversations highlight the importance of technology transfer and the capability of the tech transfer receiving sites (the facilities in these countries that would then produce vaccines locally), including having specialized equipment and personnel.
Dear President Biden and Congress: Time for US to Lead Response to the Growing COVID-19 Global Vaccine Crisis
Today we joined colleagues from CSIS, Duke University, and the COVID Collective in an open letter to the Biden Administration and US Congress with a clear message: to hasten the end of the COVID-19 global pandemic, American leadership is required to ensure universal global access to high-quality and safe vaccines, support rapid vaccine distribution and administration, and build a sustainable global network of vaccine manufacturing capacity. Vaccines offer an exit route out of the pandemic – but only if they reach a critical mass of people in need across continents, socioeconomic strata, and marginalized populations.
The UK Aid Cuts to UNFPA: Ripple Effects in Sexual and Reproductive Health Product Markets with Outsized Impacts for Women and Girls
The UN Population Fund (UNFPA) recently revealed that the UK government intends to cut aid to its supplies program by 85 percent, slashing Britain’s original 2021 commitment from $211 million to $32 million.
India’s second COVID-19 wave has been explosive, reaching world record totals of over 300,000 daily officially reported cases. The true number is likely to be much higher, with a large number of cases missed as indicated by the delays in testing and rapidly rising positivity rates - currently one in every four people tested are positive for COVID-19 across India. Leading models estimate that there could be over 1 million cases per day. The health service has collapsed, with queues of ambulances parked outside full hospitals, oxygen and drug shortages in multiple states, and life-saving non-COVID services interrupted.
It is easy to critique humanitarian organizations for inefficiencies and other flaws in their coordination functions. But deeper examination of issues such as media exposure and incentives to coordinate makes it clearer that, given their current funding model, their actions may be rational institutional behavior.